Citius Pharmaceuticals Inc (CTXR)

[ash111]

look at these numbers: pipeline includes two drugs with $500M opportunities that have already progressed through P2 studies. Mino-Lok is already in P3.
Just Received "Fast Track" Designation By FDA For Mino-Lok™ Investigational Trial. There are currently no approved therapies to salvage infected central venous catheters ("CVCs"), a potential $750 million sector in the US alone.

Also The second promising drug-Hydro-Lido-
Next Catalyst- achieved excellent results. No competitors. way undervalued per cash on hand alone!.  Chairman, Mr. Leonard Mazur, invested $1.7 million (25% of the total), from his Nostro account. financing completed( raised $26.8m cash). share price about to get a big boost.